SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-030002
Filing Date
2024-03-01
Accepted
2024-03-01 16:30:20
Documents
3
Group Members
HAN 2020 IRREVOCABLE TRUST

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm247478d1_sc13da.htm SC 13D/A 59606
2 EXHIBIT A tm247478d1_ex99-a.htm EX-99.A 49809
3 EXHIBIT B tm247478d1_ex99-b.htm EX-99.B 5257
  Complete submission text file 0001104659-24-030002.txt   116111
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Subject) CIK: 0001818838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92270 | Film No.: 24710403
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10179 HUENNEKENS STREET SUITE 103 SAN DIEGO, CA 92121
Business Address
Luo Peter (Filed by) CIK: 0001907614 (see all company filings)

Type: SC 13D/A